GGrantIndex
← Leaderboards

Haresh Kirpalani

University Of Pennsylvania

$3,942,476
Attributed
$11,811,259
Total exposure
7
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY201225
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,811,259 · 7

By mechanism

U01$6,650,179 · 2
UH3$4,254,813 · 2
UG3$735,425 · 2
R03$170,842 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Infant

Research focus

InfantBronchopulmonary DysplasiaPremature InfantNational Institute Of Child Health And Human DevelopmentRespiratoryPreventLungResearch PersonnelSecondary OutcomePrimary OutcomeChildClinical TrialsIncidenceCessation Of LifeBirthSiteLifeFailurePremature BirthChildhoodGestational AgeMorbidity - Disease RatePrematureHigh Risk

Grant awards (24)

1/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial$831,827
UH3 · FY2025 · HL
1/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial$821,645
UH3 · FY2024 · HL
1/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial$693,562
UH3 · FY2023 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$246,511
UH3 · FY2023 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$264,047
UH3 · FY2022 · HL
1/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial$416,018
UG3 · FY2021 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2021 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2020 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$266,409
UH3 · FY2020 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$275,728
UH3 · FY2019 · HL
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$322,266
UH3 · FY2018 · HL
Sustained Inflation to Aerate Infant's Lungs (SAIL) Trial$990,650
U01 · FY2017 · HD · contact PI
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center$319,407
UG3 · FY2017 · HL
Respiratory function monitoring during resuscitation of extremely preterm infants: An ancillary study to the SAIL trial$85,422
R03 · FY2017 · HD
Sustained Inflation to Aerate Infant's Lungs (SAIL) Trial$1,137,210
U01 · FY2016 · HD · contact PI
Transfusion-Associated Brain Improvement (TABI) trial - CCC$243,862
U01 · FY2016 · HL · contact PI
Respiratory function monitoring during resuscitation of extremely preterm infants: An ancillary study to the SAIL trial$85,420
R03 · FY2016 · HD
Sustained Inflation to Aerate Infant's Lungs (SAIL) Trial$1,123,568
U01 · FY2015 · HD · contact PI
Transfusion-Associated Brain Improvement (TABI) trial - CCC$240,112
U01 · FY2015 · HL · contact PI
Sustained Inflation to Aerate Infant's Lungs (SAIL) Trial$1,161,327
U01 · FY2014 · HD · contact PI
Transfusion-Associated Brain Improvement (TABI) trial - CCC$239,985
U01 · FY2014 · HL · contact PI
The SAIL trial [Sustained Aeration of Infant Lungs]$1,091,491
U01 · FY2013 · HD · contact PI
Transfusion-Associated Brain Improvement (TABI) trial - CCC$237,462
U01 · FY2013 · HL · contact PI
Transfusion-Associated Brain Improvement (TABI) trial - CCC$184,512
U01 · FY2012 · HL · contact PI